Definition and Overview
Drug-induced autonomic side effects refer to conditions in which medications administered for therapeutic purposes unintentionally cause dysfunction of the autonomic nervous system. They occur through mechanisms that directly act on autonomic neurotransmitter receptors (norepinephrine, acetylcholine, dopamine, etc.) or alter the synthesis, degradation, and reuptake of neurotransmitters.
Drug-induced autonomic side effects can affect various autonomic regulatory functions, including the cardiovascular system (blood pressure, heart rate), digestive system (gastrointestinal motility), urinary system (bladder function), skin (sweating, vascular responses), and thermoregulation. The risk and severity of side effects are greater in the elderly, patients with underlying autonomic disorders, and those on polypharmacy.
Major Autonomic Side Effects by Drug Class
Anticholinergic drugs block muscarinic acetylcholine receptors, thereby suppressing parasympathetic function. These include antihistamines, tricyclic antidepressants (amitriptyline, imipramine), bladder relaxants (oxybutynin, tolterodine), antiparkinsonian agents (trihexyphenidyl), and some antipsychotics. Major side effects include dry mouth, constipation, urinary retention, tachycardia, blurred vision, decreased sweating, and cognitive impairment (especially in the elderly).
Alpha-1 blockers (doxazosin, terazosin, prazosin) block alpha-1 receptors in vascular smooth muscle, causing vasodilation. Orthostatic hypotension is the primary side effect, with fall risk being particularly elevated during initial dosing or dose escalation.
Beta-blockers (metoprolol, atenolol, carvedilol) block beta-adrenergic receptors, causing bradycardia, exercise intolerance, peripheral vasoconstriction (exacerbation of Raynaud's phenomenon), and bronchoconstriction (non-selective beta-blockers).
Antiparkinsonian agents (levodopa, dopamine agonists) act on dopamine receptors in the autonomic nervous system, inducing orthostatic hypotension, hyperhidrosis, and gastrointestinal dysmotility.
Antipsychotics (haloperidol, clozapine, olanzapine) cause orthostatic hypotension, tachycardia, and sweating abnormalities through alpha-1 blockade and anticholinergic effects [1].
Chemotherapeutic agents (vincristine, cisplatin, paclitaxel) can cause autonomic neuropathy as part of peripheral neurotoxicity, resulting in orthostatic hypotension, gastrointestinal dysmotility, and bladder dysfunction [3].
Pathophysiology
The major mechanisms of drug-induced autonomic side effects are as follows.
Receptor blockade or activation mechanisms include muscarinic receptor blockade (anticholinergic effect), alpha- or beta-adrenergic receptor blockade, and dopamine receptor modulation.
Alterations in neurotransmitter metabolism include monoamine oxidase inhibition (MAOI), catecholamine reuptake inhibition, and adrenergic synthesis inhibition.
Through neurotoxicity mechanisms, chemotherapeutic agents can directly damage autonomic nerve fibers (particularly small-diameter unmyelinated C-fibers), potentially causing permanent autonomic neuropathy [3].
In the elderly, the risk of adverse effects at equivalent doses is increased due to reduced drug metabolism (decreased hepatic metabolism, decreased renal excretion), altered receptor sensitivity, and baseline decline in autonomic function [4].
Symptoms
Blood pressure-related symptoms include orthostatic hypotension (systolic blood pressure drop of 20 mmHg or more within 3 minutes of standing), supine hypertension, and increased blood pressure variability.
Heart rate-related symptoms include tachycardia (anticholinergic effect), bradycardia (beta-blockers), and decreased heart rate variability.
Gastrointestinal symptoms include constipation (anticholinergic effect), gastroparesis, and reduced gastrointestinal motility.
Urinary symptoms may include urinary retention (anticholinergic effect) and overactive bladder.
Other symptoms include dry mouth, decreased or increased sweating, blurred vision, and thermoregulatory dysfunction.
Diagnosis
Assessment of autonomic side effects is based on a detailed medication history and analysis of the temporal relationship between drug initiation and symptom onset. Autonomic function tests (tilt-table test, HRV analysis, QSART) can objectively quantify functional abnormalities.
Anticholinergic burden scales (e.g., ACB scale) are used in clinical practice to quantify anticholinergic risk in patients on polypharmacy.
Treatment and Management
After identifying the causative drug, discontinuation or dose reduction is the priority when feasible. Switching to an alternative medication (an equally effective drug with fewer autonomic side effects) is recommended.
Orthostatic hypotension-related side effects should first be managed with non-pharmacological measures (rising slowly, adequate fluid and salt intake, compression stockings).
Management of anticholinergic side effects includes adequate hydration (for dry mouth), dietary fiber and stool softeners (for constipation), and bladder retraining (for urinary retention).
For chemotherapy-induced autonomic neuropathy, dose adjustment or discontinuation of the causative agent should be considered, along with supportive care (symptom management).
In patients on polypharmacy, regular medication reconciliation should be performed to eliminate unnecessary medications and minimize the risk of autonomic side effects [4].
---
This information is provided for medical educational purposes only and does not replace professional medical advice. If you are experiencing symptoms, please consult a specialist. Contact: OSANG Neurosurgery 1599-5453 | osns.co.kr